Apollo Hospitals Enterprise Limited
APOLLOHOSP
Rang in Aktien
#1775
Apollo Hospitals Enterprise Limited, through its group entities, delivers a... Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
Aktienkurs
$83.93
Marktkapitalisierung
$12.07B
Veränderung (1 Tag)
-1.23%
Veränderung (1 Jahr)
-7.79%
Land
IN
Handel Apollo Hospitals Enterprise Limited (APOLLOHOSP)
Kategorie
Healthcare
Gewinn für Apollo Hospitals Enterprise Limited (APOLLOHOSP)
Gewinn im Jun 2026 TTM: $317.50M
Laut den aktuellen Finanzberichten von Apollo Hospitals Enterprise Limited betragen die aktuellen Gewinne des Unternehmens $317.50M. Im Jahr 2024 erzielte das Unternehmen einen Gewinn von $165.56M, eine Steigerung gegenüber dem Gewinn im Jahr 2023, der $133.91M betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Apollo Hospitals Enterprise Limited von 2005 bis 2026
Gewinn am Ende jedes Jahres
| Jahr | Gewinn | ändert |
|---|---|---|
| 2026 (TTM) | $317.50M | 33.17% |
| 2025 | $238.42M | 44.01% |
| 2024 | $165.56M | 23.63% |
| 2023 | $133.91M | -35.88% |
| 2022 | $208.85M | 590.24% |
| 2021 | $30.26M | -65.30% |
| 2020 | $87.21M | 62.14% |
| 2019 | $53.79M | 104.25% |
| 2018 | $26.33M | -23.10% |
| 2017 | $34.25M | -31.69% |
| 2016 | $50.13M | -32.69% |
| 2015 | $74.48M | -3.94% |
| 2014 | $77.54M | 3.33% |
| 2013 | $75.04M | 16.73% |
| 2012 | $64.29M | 9.63% |
| 2011 | $58.64M | 33.25% |
| 2010 | $44.01M | 66.26% |
| 2009 | $26.47M | -10.97% |
| 2008 | $29.73M | 5.27% |
| 2007 | $28.24M | 86.81% |
| 2006 | $15.12M | 25.12% |
| 2005 | $12.08M | 0.00% |
Gewinn ähnlicher Unternehmen oder Konkurrenten
| Unternehmen | Gewinn | Gewinnunterschied | Land |
|---|---|---|---|
| $9.87B | 3,008.95% |
US
|
|
| - | - |
DE
|
|
| $3.87B | 1,117.31% |
US
|
|
| $687.82M | 116.63% |
SA
|
|
| $1.25B | 292.66% |
BR
|
